Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.24.1.1.u2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Common Class A [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2022 $ 1 $ 158,629 $ (153,464) $ 5,166
Balance, shares at Dec. 31, 2022 3 2,918,017      
Sale of common stock from public offering 6,578 6,578
Sale of common stock from public offering, shares     901,275      
Fair value of vested restricted stock awards, stock options and warrants 903 903
Fair value of vested restricted stock awards, stock options and warrants, shares     49,596      
Net loss (5,514) (5,514)
Deemed dividend due to warrant reset 164 (164)
Issuance of shares for fractional adjustments related to Reverse Stock Split
Issuance of shares for fractional adjustments related to Reverse Stock Split, shares     31,195      
Balance at Mar. 31, 2023 $ 1 166,274 (159,142) 7,133
Balance, shares at Mar. 31, 2023 3 3,900,083      
Balance at Dec. 31, 2023 $ 2,980 $ 2 175,765 (175,622) 3,125
Balance, shares at Dec. 31, 2023 3,000 3 21,231,355      
Sale of common stock from public offering $ 5 12,343 12,348
Sale of common stock from public offering, shares     46,580,516      
Fair value of vested restricted stock awards, stock options and warrants 328 328
Fair value of vested restricted stock awards, stock options and warrants, shares     4,514      
Fair value of common shares issued as payment on notes payable $ 1 1,719 1,720
Fair value of common shares issued as payment on notes payable, shares     11,484,403      
Series C Preferred Stock dividends payable (75) (75)
Net loss (3,445) (3,445)
Balance at Mar. 31, 2024 $ 2,980 $ 8 $ 190,155 $ (179,142) $ 14,001
Balance, shares at Mar. 31, 2024 3,000 3 79,300,788